Wilson John's Insider Trades & SAST Disclosures
Wilson John's most recent trade in Rapid Micro Biosystems Inc - Ordinary Shares - Class A was a trade of 9,872 Class A Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on March 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Wilson John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 09 Mar 2025 | 9,872 | 232,474 | - | 2.4 | 23,594 | Class A Common Stock |
| Rollins, Inc. | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 11,750 | 672,257 (0%) | 0% | 0 | Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.33 per share. | 20 Feb 2025 | 1,452 | 670,805 (0%) | 0% | 51.3 | 74,531 | Common Stock |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 89,000 | 89,000 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 44,000 | 242,346 | - | 0 | Class A Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.01 per share. | 18 Feb 2025 | 922 | 660,507 (0%) | 0% | 50.0 | 46,109 | Common Stock |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 11 Feb 2025 | 7,075 | 198,346 | - | 2.7 | 18,961 | Class A Common Stock |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.10 per share. | 06 Feb 2025 | 4,505 | 205,421 | - | 3.1 | 13,966 | Class A Common Stock |
| Rollins, Inc. | John F. Wilson | Director, EXECUTIVE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.32 per share. | 28 Jan 2025 | 5,368 | 661,429 (0%) | 0% | 49.3 | 264,750 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.50 per share. | 27 Jan 2025 | 8,372 | 666,797 (0%) | 0% | 49.5 | 414,414 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.46 per share. | 22 Jan 2025 | 3,299 | 675,169 (0%) | 0% | 48.5 | 159,870 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 48.77 per share. | 13 Dec 2024 | 10,252 | 678,468 (0%) | 0% | 48.8 | 499,990 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Nov 2024 | 16,500 | 668,216 (0%) | 0% | 0 | Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 720 | 684,716 (0%) | 0% | 0 | Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Aug 2024 | 720 | 685,436 (0%) | 0% | 0 | Common Stock | |
| Encore Wire Corp. | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 1,250 | 14,100 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 4,348 | 11,108 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.98 per share. | 11 Mar 2024 | 9,569 | 188,738 | - | 1.0 | 9,387 | Class A Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 44.29 per share. | 06 Mar 2024 | 780 | 686,156 (0%) | 0% | 44.3 | 34,546 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 44.29 per share. | 06 Mar 2024 | 414 | 686,936 (0%) | 0% | 44.3 | 18,336 | Common Stock |
| Rollins, Inc. | Wilson F. John | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 9,750 | 687,350 (0%) | 0% | 0 | Common Stock | |
| Rollins, Inc. | F. John Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.05 per share. | 16 Feb 2024 | 924 | 677,600 (0%) | 0% | 41.0 | 37,930 | Common Stock |
| Rapid Micro Biosystems Inc... | Wilson John | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.96 per share. | 12 Feb 2024 | 5,809 | 198,307 | - | 1.0 | 5,577 | Class A Common Stock |
| Rapid Micro Biosystems Inc... | Wilson John | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 79,000 | 79,000 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 39,000 | 204,116 | - | 0 | Class A Common Stock | |
| Rollins, Inc. | F. John Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.25 per share. | 26 Jan 2024 | 5,380 | 678,524 (0%) | 0% | 43.3 | 232,685 | Common Stock |
| Rollins, Inc. | F. Wilson John | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.23 per share. | 26 Jan 2024 | 4,722 | 687,839 (0%) | 0% | 43.2 | 204,132 | Common Stock |
| Rollins, Inc. | Wilson John F. | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.23 per share. | 26 Jan 2024 | 3,935 | 683,904 (0%) | 0% | 43.2 | 170,110 | Common Stock |
| Rollins, Inc. | Wilson John F. | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.22 per share. | 23 Jan 2024 | 4,384 | 692,561 (0%) | 0% | 44.2 | 193,860 | Common Stock |
| Rollins, Inc. | F. Wilson John | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.08 per share. | 22 Jan 2024 | 3,211 | 696,945 (0%) | 0% | 44.1 | 141,541 | Common Stock |
| Tigo Energy Inc. | John Andrew Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 16,304 | 16,304 | - | 0 | Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2023 | 2,415 | 738,537 (0%) | 0% | 0 | Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Jul 2023 | 3,040 | 740,952 (0%) | 0% | 0 | Common Stock | |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Encore Wire Corp. | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 1,250 | 12,850 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 42.45 per share. | 28 Apr 2023 | 40,499 | 743,992 (0%) | 0% | 42.5 | 1,719,183 | Common Stock |
| RPC, Inc. | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 6,766 | 10,184 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 3,631 | 6,760 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 210,900 | 210,900 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc... | John Wilson | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 100,900 | 158,377 | - | 0 | Class A Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 8,250 | 784,491 (0%) | 0% | 0 | Common Stock | |
| Rapid Micro Biosystems Inc... | John Wilson | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. | 13 Feb 2023 | 7,075 | 57,477 | - | 1.3 | 9,198 | Class A Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.68 per share. | 30 Jan 2023 | 5,412 | 776,241 (0%) | 0% | 35.7 | 193,100 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 26 Jan 2023 | 5,412 | 786,163 (0%) | 0% | 36.1 | 195,590 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.14 per share. | 26 Jan 2023 | 4,510 | 781,653 (0%) | 0% | 36.1 | 162,991 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.32 per share. | 23 Jan 2023 | 5,559 | 791,575 (0%) | 0% | 36.3 | 201,903 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.15 per share. | 23 Jan 2023 | 4,063 | 797,134 (0%) | 0% | 36.1 | 146,877 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.15 per share. | 23 Jan 2023 | 3,383 | 801,197 (0%) | 0% | 36.1 | 122,295 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Sale of securities on an exchange or to another person at price $ 39.54 per share. | 26 Oct 2022 | 32,000 | 804,580 (0%) | 0% | 39.5 | 1,265,280 | Common Stock |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Encore Wire Corp. | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 1,250 | 11,600 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| RPC, Inc. | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 2,418 | 3,418 (0%) | 0% | 0 | Common Stock, $.10 Value | |
| Marine Products Corp | John F. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2022 | 2,129 | 3,129 (0%) | 0% | 0 | Common Stock, $.10 Par Value | |
| Rapid Micro Biosystems Inc... | John Wilson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 122,500 | 122,500 | - | - | Stock Option (Right to Buy) | |
| Rapid Micro Biosystems Inc... | John Wilson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 61,250 | 61,250 | - | 0 | Class A Common Stock | |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.96 per share. | 28 Jan 2022 | 5,412 | 836,580 (0%) | 0% | 30.0 | 162,144 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 29.70 per share. | 26 Jan 2022 | 50,000 | 848,080 (0%) | 0% | 29.7 | 1,485,000 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.70 per share. | 26 Jan 2022 | 6,088 | 841,992 (0%) | 0% | 29.7 | 180,814 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, VICE CHAIRMAN | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.90 per share. | 24 Jan 2022 | 12,434 | 798,080 (0%) | 0% | 31.9 | 396,645 | Rollins, Inc. Common Stock $1 Par Value |
| Marker Therapeutics Inc | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 12,658 | 7,812,008 (16%) | 0% | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Encore Wire Corp. | John H. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 1,250 | 10,350 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Marker Therapeutics Inc | John Wilson | Director | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 16 Mar 2021 | 1,714,285 | 7,799,350 (16%) | 3% | 1.8 | 2,999,999 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 09 Mar 2021 | 52,440 | 5,510,514 | - | 31.3 | 1,641,157 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.70 per share. | 09 Mar 2021 | 30,506 | 5,480,008 | - | 31.7 | 966,921 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 09 Mar 2021 | 28,402 | 5,451,605 | - | 30.9 | 878,449 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.59 per share. | 09 Mar 2021 | 25,256 | 5,426,349 | - | 31.6 | 797,921 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.30 per share. | 09 Mar 2021 | 17,480 | 3,197,475 | - | 31.3 | 547,052 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.87 per share. | 09 Mar 2021 | 10,188 | 5,415,261 | - | 30.9 | 314,535 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.70 per share. | 09 Mar 2021 | 10,169 | 3,187,306 | - | 31.7 | 322,318 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 09 Mar 2021 | 9,467 | 3,177,838 | - | 30.9 | 292,807 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.60 per share. | 09 Mar 2021 | 8,418 | 3,169,420 | - | 31.6 | 265,974 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 30.87 per share. | 09 Mar 2021 | 3,397 | 3,165,723 | - | 30.9 | 104,876 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 09 Mar 2021 | 2,308 | 5,412,953 | - | 31.6 | 72,997 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 32.31 per share. | 09 Mar 2021 | 900 | 5,425,449 | - | 32.3 | 29,081 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 09 Mar 2021 | 769 | 3,164,954 | - | 31.6 | 24,322 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | Sale of securities on an exchange or to another person at price $ 32.31 per share. | 09 Mar 2021 | 300 | 3,169,120 | - | 32.3 | 9,694 | Common Stock |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 37.04 per share. | 26 Jan 2021 | 60,000 | 816,602 (0%) | 0% | 37.0 | 2,222,400 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.95 per share. | 26 Jan 2021 | 6,088 | 810,514 (0%) | 0% | 35.0 | 212,776 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.04 per share. | 23 Jan 2021 | 6,088 | 756,602 (0%) | 0% | 37.0 | 225,500 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.15 per share. | 23 Jan 2021 | 4,863 | 767,553 (0%) | 0% | 37.1 | 180,660 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.15 per share. | 23 Jan 2021 | 4,863 | 762,690 (0%) | 0% | 37.1 | 180,660 | Rollins, Inc. Common Stock $1 Par Value |
| Rollins, Inc. | John F. Wilson | Director, Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.02 per share. | 22 Jan 2021 | 3,335 | 772,416 (0%) | 0% | 37.0 | 123,462 | Rollins, Inc. Common Stock $1 Par Value |
| MDU Resources Group Inc | John K. Wilson | Director | Grant, award, or other acquisition of securities at price $ 25.40 per share. | 17 Nov 2020 | 4,921 | 138,808 (0%) | 0% | 25.4 | 124,998 | Common Stock |
| Kalaris Therapeutics Inc. | John Wilson | Director | 03 Aug 2020 | 4,745,943 | 0 | - | - | Series A-3 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | John Wilson | Director | 03 Aug 2020 | 3,499,001 | 0 | - | - | Series A-3 Convertible Preferred Stock | ||
| Kalaris Therapeutics Inc. | John Wilson | Director | 03 Aug 2020 | 3,184,758 | 3,214,955 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | John Wilson | Director | 03 Aug 2020 | 2,347,999 | 5,562,954 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | John Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Encore Wire Corp. | John H. Wilson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2020 | 1,100 | 9,100 (0%) | 0% | 0 | Common Stock, par value $0.01 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges